PharmaLedger Association – Platform Launch Lessons Learned and Outlook

Natalia Sofia ,
Natalia Sofia
Daniel Fritz ,
Daniel Fritz
Disa Lee Choun ,
Disa Lee Choun
Moderator: Anca Petre
Moderator: Anca Petre

Published: 20.04.2024.

Biochemistry

Volume 7, Issue 1 (2024)

https://doi.org/10.30953/bhty.v7.313

Abstract

The panel explores the application of blockchain technology within the healthcare sector, focusing on its potential to enhance trust, transparency, and connectivity while reinforcing patient-centered control of data access. The discussion examines the opportunities for patient empowerment and improved patient access to healthcare information through decentralized ledger technology. The panel features industry experts providing insights into current trends, challenges, and future prospects of blockchain in pharmaceuticals, emphasizing broader use cases beyond specific organizations.  Objectives Gain a comprehensive understanding of the role of blockchain technology in the pharmaceutical industry and its potential impact on patient care and relationships with the healthcare system. Explore the opportunities presented by blockchain for improving trust, transparency, and audibility in data sharing within the healthcare and medical environment. Understand the significance of patient-centered control in accessing, storing, and utilizing healthcare data and how blockchain can contribute to enhancing patient empowerment. Discuss the challenges and considerations associated with implementing blockchain in the pharmaceutical sector and explore strategies to overcome them while ensuring compliance with regulatory frameworks.

Keywords

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles